Who owns INOZYME PHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Inozyme Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Inozyme Pharma stock

Who bought or sold INOZYME PHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Adage Capital Partners GP 5.3M $41M -4% Mar 2024
 View chart
Pivotal bioVenture Partners Investment Advisor 4.5M $34M 0% Mar 2024
 View chart
Sofinnova Ventures 4.3M $33M 0% Mar 2024
 View chart
Rock Springs Capital Management 3.7M $28M 0% Mar 2024
 View chart
Eventide Asset Management 3.2M $24M 0% Mar 2024
 View chart
BlackRock 3.1M $24M 38% Mar 2024
 View chart
Samlyn Capital 2.9M $22M -14% Mar 2024
 View chart
Affinity Asset Advisors 2.6M $20M 40% Mar 2024
 View chart
NEA Management Company 2.4M $19M 0% Mar 2024
 View chart
Vanguard Group 2.4M $19M 1% Mar 2024
 View chart
FMR 2.0M $15M -20% Mar 2024
 View chart
Samsara BioCapital 1.6M $12M 0% Mar 2024
 View chart
Sphera Funds Management 1.4M $11M -12% Mar 2024
 View chart
Blue Owl Capital Holdings 1.3M $9.7M 0% Mar 2024
 View chart
Geode Capital Management 1.1M $8.2M 30% Mar 2024
 View chart
Woodline Partners 888k $6.8M 100% Mar 2024
 View chart
State Street Corporation 881k $6.7M 18% Mar 2024
 View chart
Millennium Management 704k $5.4M -23% Mar 2024
 View chart
Knott David M Jr 565k $4.3M 0% Mar 2024
 View chart
Kennedy Capital Management 438k $3.4M 52% Mar 2024
 View chart
Northern Trust 420k $3.2M 25% Mar 2024
 View chart
Goldman Sachs Group 410k $3.1M 13% Mar 2024
 View chart
Laurion Capital Management 402k $3.1M -28% Mar 2024
 View chart
Exome Asset Management 273k $2.1M 100% Mar 2024
 View chart
Wellington Management Company 244k $1.9M 100% Mar 2024
 View chart
Parkman Healthcare Partners 223k $1.7M 27% Mar 2024
 View chart
Overbrook Management Corp. 219k $1.7M 0% Mar 2024
 View chart
UBS O'Connor 183k $1.4M 100% Mar 2024
 View chart
Dimensional Fund Advisors 175k $1.3M 174% Mar 2024
 View chart
Renaissance Technologies 174k $1.3M -21% Mar 2024
 View chart
Bank of New York Mellon 164k $1.3M 4% Mar 2024
 View chart
Nuveen Asset Management 161k $1.2M 17% Mar 2024
 View chart
GSA Capital Partners 131k $1.0M -22% Mar 2024
 View chart
Charles Schwab Investment Management 127k $969k 4% Mar 2024
 View chart
Morgan Stanley 124k $952k 371% Mar 2024
 View chart
Superstring Capital Management 113k $864k -9% Mar 2024
 View chart
Citadel Advisors 100k $768k -43% Mar 2024
 View chart
Schonfeld Strategic Advisors 75k $573k -31% Mar 2024
 View chart
Rhumbline Advisers 63k $484k 5% Mar 2024
 View chart
Springbok Capital Management 62k $478k 100% Mar 2024
 View chart
Jpmorgan Chase & Co 62k $472k 79% Mar 2024
 View chart
Bank of America Corporation 60k $459k -24% Mar 2024
 View chart
American Century Companies 51k $394k 185% Mar 2024
 View chart
UBS Group 48k $367k 4% Mar 2024
 View chart
Susquehanna International 46k $354k -82% Mar 2024
 View chart
ALPS Advisors 44k $334k 3% Mar 2024
 View chart
Two Sigma Advisers 41k $316k -42% Mar 2024
 View chart
Barclays 37k $282k -47% Mar 2024
 View chart
Connor, Clark & Lunn Investment Management 35k $267k 100% Mar 2024
 View chart
Balyasny Asset Management 31k $240k 100% Mar 2024
 View chart
Two Sigma Investments 30k $229k -44% Mar 2024
 View chart
Jane Street 29k $223k -43% Mar 2024
 View chart
AQR Capital Management 28k $212k -40% Mar 2024
 View chart
MetLife Investment Advisors 27k $113k 47% Dec 2023
 View chart
Bailard 24k $186k 100% Mar 2024
 View chart
American International 24k $180k -1% Mar 2024
 View chart
Denali Advisors 22k $169k 0% Mar 2024
 View chart
Manufacturers Life Insurance Company 19k $144k -24% Mar 2024
 View chart
Invesco 18k $141k 3% Mar 2024
 View chart
Alliancebernstein 18k $140k 0% Mar 2024
 View chart
Bridgeway Capital Management 18k $136k -81% Mar 2024
 View chart
Lido Advisors 17k $131k 100% Mar 2024
 View chart
Wells Fargo & Company 17k $129k 15% Mar 2024
 View chart
Parallel Advisors 16k $123k 0% Mar 2024
 View chart
Ing Investment Management 16k $122k 16% Mar 2024
 View chart
Deutsche Bank Aktiengesellschaft 15k $118k -5% Mar 2024
 View chart
T. Rowe Price Associates 14k $109k 12% Mar 2024
 View chart
SG Americas Securities 14k $107k -34% Mar 2024
 View chart
Resources Investment Advisors 14k $105k 100% Mar 2024
 View chart
New York State Common Retirement Fund 13k $102k 0% Mar 2024
 View chart
Citigroup 9.0k $69k 34% Mar 2024
 View chart
Summit Investment Advisors 4.8k $37k 0% Mar 2024
 View chart
California State Teachers Retirement System 4.8k $37k -36% Mar 2024
 View chart
Legal & General Group 4.0k $31k 0% Mar 2024
 View chart
Metropolitan Life Insurance Company 2.7k $21k -5% Mar 2024
 View chart
Royal Bank of Canada 2.0k $15k -87% Mar 2024
 View chart
Group One Trading 1.2k $9.0k 17% Mar 2024
 View chart
Amalgamated Bank 1.1k $9.0k -61% Mar 2024
 View chart
BFSG 500.00 $3.8k 100% Mar 2024
 View chart
Tower Research Capital 398.00 $3.0k -95% Mar 2024
 View chart
Simplex Trading 168.00 $1.0k 100% Mar 2024
 View chart
Signature 113.00 $865.998100 100% Mar 2024
 View chart
ICA Group Wealth Management 85.00 $650.998000 100% Mar 2024
 View chart
Advisor Group Holdings 50.00 $383.000000 0% Mar 2024
 View chart
GAMMA Investing 48.00 $368.001600 100% Mar 2024
 View chart
NISA Investment Advisors 24.00 $184.000800 100% Mar 2024
 View chart
Nelson, Van Denburg & Campbell Wealth Management 9.00 $68.000400 100% Mar 2024
 View chart
CWM 3.00 $0 100% Mar 2024
 View chart

Who sold out of Inozyme Pharma?

Fund or Company Name Date Sold Shares Held Valued At
Octagon Capital Advisors Dec 2023 400k $1.7M
MPM Oncology Impact Management Sep 2023 327k $1.4M
Virtu Financial Dec 2023 27k $114k
Bank Of Montreal Dec 2023 22k $99k
Values First Advisors Dec 2023 14k $59k
Florida State Board of Administration Dec 2023 12k $53k